Editorial: TIPS in the Era of Aging and Metabolic Comorbidity: Rethinking Risks and Rewards
- 16 January 2026
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 63 (7) , 1037-1039
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Metabolic Dysfunction Associated to Steatotic Liver Disease: A ReviewMetabolic Syndrome and Related Disorders, 2025
- Diabetes Mellitus is a Risk Factor for Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic ShuntAlimentary Pharmacology & Therapeutics, 2025
- Metabolic dysfunction-associated steatotic liver disease and diabetes: Together against the heartWorld Journal of Hepatology, 2025
- End-procedural adherence to recommended hemodynamic targets does not improve the outcome of elective TIPS in patients with cirrhosisHepatology, 2025
- EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)Journal of Hepatology, 2024
- Predictive Accuracy Comparison of Prognostic Scoring Systems for Survival in Patients Undergoing TIPS Placement: A Systematic Review and Meta-analysisAcademic Radiology, 2023
- The Impact of Transjugular Intrahepatic Portosystemic Shunt on Nutrition in Liver Cirrhosis Patients: A Systematic ReviewNutrients, 2023
- Nonalcoholic Fatty Liver Disease and Diabetes Mellitus Are Associated With Post–Transjugular Intrahepatic Portosystemic Shunt Renal Dysfunction: An Advancing Liver Therapeutic Approaches Group StudyLiver Transplantation, 2021
- Consequences of Perceived Stigma Among Patients with CirrhosisDigestive Diseases and Sciences, 2013
- Effect of Transjugular Intrahepatic Portosystemic Shunt (TIPS) on Glycemic Control in Cirrhotic Patients With Diabetes MellitusAmerican Journal of Gastroenterology, 1998